Revel Pharmaceuticals
Biotechnology company commercializing therapeutic enzymes to degrade age associated molecule damage.
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.
Visit website: https://www.revelpharmaceuticals.com/
Details last updated 03-Feb-2020
People at Revel Pharmaceuticals
Revel Pharmaceuticals News
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Revel pharmaceutics raised $8.4M to push enzyme therapies to clinic
KIZOO Technology Ventures - 17-Mar-2022
Funds will be used to develop enzymes that repair collagen and reverse ageing or disease
Read more...Revel pharmaceuticals restores tissue function using AGE-cleaving enzymes
Longevity Technology - 12-Oct-2021
A unique treatment approach for ageing; will soon begin trials in animals and human cadaver tissue
Read more...Fight Aging! reports back from SENS Research Foundation Pitch Day
Fight Aging! - 20-Jan-2020
When some of these succeed in human trials even more money will pile in to fund further advances
Read more...
